About 4 results found for searched term "Dovitinib" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1697 | Dovitinib | VEGFR/PDGFR |
| TKI258, CHIR-258 | ||
| Dovitinib (TKI258, CHIR-258) is a small-molecule multitargeted receptor tyrosine kinase inhibitor. | ||
| M5592 | Dovitinib (TKI-258) Dilactic Acid | VEGFR/PDGFR |
| TKI-258 | ||
| Dovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM. | ||
| M14898 | Dovitinib lactate | FLT3 |
| CHIR-258 lactate; TKI-258 lactate | ||
| Dovitinib lactate (TKI258 lactate) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β, respectively. | ||
| M43439 | Dovitinib-RIBOTAC TFA | PROTAC |
| Dovitinib RIBOTAC TFA is a targeted RNA degrader that cleaves pre-miR-21 with enhanced potency and selectivity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
